SlideShare una empresa de Scribd logo
1 de 18
Stephanie Nishi Spencer Lee Andrew Walnum Gurmeet Marwaha Period 5, Biotechnology
The Scenario What can Biotex offer this scientist in order to avoid going out of business?
Biotex: Question 1 Is the MA Scientist’s patent legitimate?  ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],Biotex: Question 1 FDA POINT OF VIEW – has the scientist been investigated?
[object Object],[object Object],Biotex: Question 1 Patient Advocacy Group Opinion
Biotex: Question 2 Is there any way to fight the patent and get out of paying the $20 million?   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Biotex: Question 2 Is there any way to fight the patent and get out of paying the $20 million?   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],Drug Inventor has the right to charge buyers directly for using his drug However, as you will see in the following slide, there are  MANY types of patents  that protect specific parts of the inventor’s research – e.g. method/process of drug creation, specific components of drug, etc.
Type Description/Regulations When is it used? Applicable to Dilmena #6? Composition ,[object Object],[object Object],[object Object],To form drugs by combining 2 ingredients, known or unknown, and claiming that specific combination as one’s own research Maybe. MA Scientist could have patented his specific combination of the protein and other materials used to extract the protein as his OWN research. He MUST have stated the specific application and function of the protein to receive this patent Formulation ,[object Object],[object Object],[object Object],[object Object],Allows inventor to control means of manufacturing his drug/research No. There is no evidence at this time that the MA Scientist PRODUCED a drug based on his research of the cancer-curing protein.  Biotex cannot be held responsible for the production of the drug, but the rights of usage of the protein remain unclear. Method or Process Protects the process or method used to PRODUCE the drug Patents method of harvesting, extracting,  or fabricating specific components of a product of research Yes. MA Scientist could patent the way he extracted the cancer-curing protein
Type Description/Regulations When is it used? Applicable to Dilemna #6? Use or Application Patents the effect of the compound, composition, or drug product on specific living organisms (e.g. humans, pets, etc.) Patents rights of usage of component for specific causes Yes. This is a worst-case scenario.  MA Scientist, if he stated that this protein cures cancer, patented rights over the application of this protein as a cure for cancer. Compound  ,[object Object],[object Object],[object Object],[object Object],Allows inventor to claim rights over discovery of the leaves with the cancer-curing protein Yes. This is also the worst-case scenario.  MA Scientist has full legal control over the usage of these leaves.
Solution 1: Patent on Method ,[object Object],[object Object],[object Object],[object Object],[object Object]
Solution 2: Patent on Composition ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Solution 3: Possibility of Formulation Patent ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Solution 4: Patent on Compound ,[object Object],[object Object],[object Object],[object Object],[object Object]
Other Suggestions ,[object Object],[object Object],[object Object],If Biotex cannot find a way to win a lawsuit against the scientist, it may be better to develop a mirror-image of the drug molecule. ,[object Object],[object Object],[object Object]
 
Works Cited ,[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

Recent FDA Developments in Digital Health & Clinical Decision Support Software
Recent FDA Developments in Digital Health & Clinical Decision Support SoftwareRecent FDA Developments in Digital Health & Clinical Decision Support Software
Recent FDA Developments in Digital Health & Clinical Decision Support SoftwareMichael Swit
 
SEB submissions in Canada
SEB submissions in CanadaSEB submissions in Canada
SEB submissions in Canadanehagandhi68
 
Defining Probiotics: The Regulatory Challenges of Classification
Defining Probiotics: The Regulatory Challenges of ClassificationDefining Probiotics: The Regulatory Challenges of Classification
Defining Probiotics: The Regulatory Challenges of ClassificationBurdock Group Consultants
 
FDA Inspections: Handling the Consequences -- or Understanding How Ugly It C...
FDA Inspections:  Handling the Consequences -- or Understanding How Ugly It C...FDA Inspections:  Handling the Consequences -- or Understanding How Ugly It C...
FDA Inspections: Handling the Consequences -- or Understanding How Ugly It C...Michael Swit
 
Biosimilars Law in Flux
Biosimilars Law in FluxBiosimilars Law in Flux
Biosimilars Law in Fluxbriandorn
 
Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014"
Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014" Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014"
Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014" Dr. Ravi Dhar
 
Biosimilars: Regulation Issues
Biosimilars: Regulation Issues Biosimilars: Regulation Issues
Biosimilars: Regulation Issues Joseph Pategou
 
As process development and manufacturing (cmc) for biologics development-an o...
As process development and manufacturing (cmc) for biologics development-an o...As process development and manufacturing (cmc) for biologics development-an o...
As process development and manufacturing (cmc) for biologics development-an o...Steven S. Lee
 
Intellectual Property Considerations During Nonclinical Drug Development
Intellectual Property Considerations During Nonclinical Drug DevelopmentIntellectual Property Considerations During Nonclinical Drug Development
Intellectual Property Considerations During Nonclinical Drug DevelopmentMaryBreenSmith
 
FDA Enforcement: What Every Clinical Director Should Know
FDA Enforcement:  What Every Clinical Director Should KnowFDA Enforcement:  What Every Clinical Director Should Know
FDA Enforcement: What Every Clinical Director Should KnowMichael Swit
 
Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India RichaTrivedi16
 
Latest Developments in and the Future of the Regulatory Landscape for Approv...
Latest Developments in and the Future of the  Regulatory Landscape for Approv...Latest Developments in and the Future of the  Regulatory Landscape for Approv...
Latest Developments in and the Future of the Regulatory Landscape for Approv...Michael Swit
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulationraj kumar
 
Orphan drugs & Treatment of rare diseases
Orphan drugs & Treatment of rare diseasesOrphan drugs & Treatment of rare diseases
Orphan drugs & Treatment of rare diseasesEneutron
 
Bio similars-scope & future prospects in india
Bio similars-scope & future prospects in indiaBio similars-scope & future prospects in india
Bio similars-scope & future prospects in indiaShradha Basu
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsCovance
 
David.Glass.FOODIE2019.Conference.presentation.12.09.19
David.Glass.FOODIE2019.Conference.presentation.12.09.19David.Glass.FOODIE2019.Conference.presentation.12.09.19
David.Glass.FOODIE2019.Conference.presentation.12.09.19David Glass
 

La actualidad más candente (20)

Recent FDA Developments in Digital Health & Clinical Decision Support Software
Recent FDA Developments in Digital Health & Clinical Decision Support SoftwareRecent FDA Developments in Digital Health & Clinical Decision Support Software
Recent FDA Developments in Digital Health & Clinical Decision Support Software
 
SEB submissions in Canada
SEB submissions in CanadaSEB submissions in Canada
SEB submissions in Canada
 
Defining Probiotics: The Regulatory Challenges of Classification
Defining Probiotics: The Regulatory Challenges of ClassificationDefining Probiotics: The Regulatory Challenges of Classification
Defining Probiotics: The Regulatory Challenges of Classification
 
FDA Inspections: Handling the Consequences -- or Understanding How Ugly It C...
FDA Inspections:  Handling the Consequences -- or Understanding How Ugly It C...FDA Inspections:  Handling the Consequences -- or Understanding How Ugly It C...
FDA Inspections: Handling the Consequences -- or Understanding How Ugly It C...
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
Biosimilars Law in Flux
Biosimilars Law in FluxBiosimilars Law in Flux
Biosimilars Law in Flux
 
Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014"
Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014" Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014"
Dr. Ravi Dhar reviews "IP Barriers in Generic Vaccines in 2014"
 
Biosimilars: Regulation Issues
Biosimilars: Regulation Issues Biosimilars: Regulation Issues
Biosimilars: Regulation Issues
 
As process development and manufacturing (cmc) for biologics development-an o...
As process development and manufacturing (cmc) for biologics development-an o...As process development and manufacturing (cmc) for biologics development-an o...
As process development and manufacturing (cmc) for biologics development-an o...
 
What is biologic, biosimilar, and biobetter
What is biologic, biosimilar, and biobetterWhat is biologic, biosimilar, and biobetter
What is biologic, biosimilar, and biobetter
 
Intellectual Property Considerations During Nonclinical Drug Development
Intellectual Property Considerations During Nonclinical Drug DevelopmentIntellectual Property Considerations During Nonclinical Drug Development
Intellectual Property Considerations During Nonclinical Drug Development
 
Biosimilars Webinar June 29, 2016 Slides
Biosimilars Webinar June 29, 2016 SlidesBiosimilars Webinar June 29, 2016 Slides
Biosimilars Webinar June 29, 2016 Slides
 
FDA Enforcement: What Every Clinical Director Should Know
FDA Enforcement:  What Every Clinical Director Should KnowFDA Enforcement:  What Every Clinical Director Should Know
FDA Enforcement: What Every Clinical Director Should Know
 
Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India
 
Latest Developments in and the Future of the Regulatory Landscape for Approv...
Latest Developments in and the Future of the  Regulatory Landscape for Approv...Latest Developments in and the Future of the  Regulatory Landscape for Approv...
Latest Developments in and the Future of the Regulatory Landscape for Approv...
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulation
 
Orphan drugs & Treatment of rare diseases
Orphan drugs & Treatment of rare diseasesOrphan drugs & Treatment of rare diseases
Orphan drugs & Treatment of rare diseases
 
Bio similars-scope & future prospects in india
Bio similars-scope & future prospects in indiaBio similars-scope & future prospects in india
Bio similars-scope & future prospects in india
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
 
David.Glass.FOODIE2019.Conference.presentation.12.09.19
David.Glass.FOODIE2019.Conference.presentation.12.09.19David.Glass.FOODIE2019.Conference.presentation.12.09.19
David.Glass.FOODIE2019.Conference.presentation.12.09.19
 

Similar a Dilmena Powerpoint

Biosimilars. Unpacking Complex Issues
Biosimilars. Unpacking Complex IssuesBiosimilars. Unpacking Complex Issues
Biosimilars. Unpacking Complex IssuesSabah Bhatnagar
 
Regulatory requirements for the product
Regulatory requirements for the productRegulatory requirements for the product
Regulatory requirements for the productAshutoshPanday5
 
Comparative study of Patent laws In United States, Canada and Patent infringe...
Comparative study of Patent laws In United States, Canada and Patent infringe...Comparative study of Patent laws In United States, Canada and Patent infringe...
Comparative study of Patent laws In United States, Canada and Patent infringe...SriramNagarajan17
 
Market access conference NAPM
Market access conference NAPMMarket access conference NAPM
Market access conference NAPMnapmSA
 
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...Mohamed Fazil M
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsArpitha Aarushi
 
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...Ioanna Michalopoulou
 
Introduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs  - Pauwels Consulting AcademyIntroduction to Regulatory Affairs  - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting AcademyPauwels Consulting
 
Could Generic Insulin Soon Hit the U.S. Market?
Could Generic Insulin Soon Hit the U.S. Market?Could Generic Insulin Soon Hit the U.S. Market?
Could Generic Insulin Soon Hit the U.S. Market?sstrumello
 
Non-clinical drug development
Non-clinical drug developmentNon-clinical drug development
Non-clinical drug developmentJayeshRajput7
 
Generic drug approval in the United States - ANDA regulations
Generic drug approval in the United States - ANDA regulationsGeneric drug approval in the United States - ANDA regulations
Generic drug approval in the United States - ANDA regulationsSteve Zweig
 
4440642.ppt
4440642.ppt4440642.ppt
4440642.pptARUNNT2
 

Similar a Dilmena Powerpoint (20)

Biosimilars. Unpacking Complex Issues
Biosimilars. Unpacking Complex IssuesBiosimilars. Unpacking Complex Issues
Biosimilars. Unpacking Complex Issues
 
Regulatory requirements for the product
Regulatory requirements for the productRegulatory requirements for the product
Regulatory requirements for the product
 
E0421024026
E0421024026E0421024026
E0421024026
 
Comparative study of Patent laws In United States, Canada and Patent infringe...
Comparative study of Patent laws In United States, Canada and Patent infringe...Comparative study of Patent laws In United States, Canada and Patent infringe...
Comparative study of Patent laws In United States, Canada and Patent infringe...
 
Market access conference NAPM
Market access conference NAPMMarket access conference NAPM
Market access conference NAPM
 
Biosimilars.pptx
Biosimilars.pptxBiosimilars.pptx
Biosimilars.pptx
 
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
 
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
Biosimilars, Orphans, Advanced Therapy Medicines: Current regulatory issues (...
 
Introduction to Regulatory Affairs - Pauwels Consulting Academy
Introduction to Regulatory Affairs  - Pauwels Consulting AcademyIntroduction to Regulatory Affairs  - Pauwels Consulting Academy
Introduction to Regulatory Affairs - Pauwels Consulting Academy
 
Benjamin Roin, "Dormant Therapies"
Benjamin Roin, "Dormant Therapies"Benjamin Roin, "Dormant Therapies"
Benjamin Roin, "Dormant Therapies"
 
Gene patenting
Gene patentingGene patenting
Gene patenting
 
Could Generic Insulin Soon Hit the U.S. Market?
Could Generic Insulin Soon Hit the U.S. Market?Could Generic Insulin Soon Hit the U.S. Market?
Could Generic Insulin Soon Hit the U.S. Market?
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
Non-clinical drug development
Non-clinical drug developmentNon-clinical drug development
Non-clinical drug development
 
Generic drug approval in the United States - ANDA regulations
Generic drug approval in the United States - ANDA regulationsGeneric drug approval in the United States - ANDA regulations
Generic drug approval in the United States - ANDA regulations
 
4440642.ppt
4440642.ppt4440642.ppt
4440642.ppt
 
Anda
AndaAnda
Anda
 
Patent Dance
Patent DancePatent Dance
Patent Dance
 
Biologics.pptx
Biologics.pptxBiologics.pptx
Biologics.pptx
 

Último

MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLMONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLSeo
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting
 
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756dollysharma2066
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentationuneakwhite
 
Call Girls Ludhiana Just Call 98765-12871 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 98765-12871 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 98765-12871 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 98765-12871 Top Class Call Girl Service AvailableSeo
 
Call Girls Zirakpur👧 Book Now📱7837612180 📞👉Call Girl Service In Zirakpur No A...
Call Girls Zirakpur👧 Book Now📱7837612180 📞👉Call Girl Service In Zirakpur No A...Call Girls Zirakpur👧 Book Now📱7837612180 📞👉Call Girl Service In Zirakpur No A...
Call Girls Zirakpur👧 Book Now📱7837612180 📞👉Call Girl Service In Zirakpur No A...Sheetaleventcompany
 
Value Proposition canvas- Customer needs and pains
Value Proposition canvas- Customer needs and painsValue Proposition canvas- Customer needs and pains
Value Proposition canvas- Customer needs and painsP&CO
 
BAGALUR CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRL
BAGALUR CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRLBAGALUR CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRL
BAGALUR CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRLkapoorjyoti4444
 
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptxB.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptxpriyanshujha201
 
Call Girls Hebbal Just Call 👗 7737669865 👗 Top Class Call Girl Service Bangalore
Call Girls Hebbal Just Call 👗 7737669865 👗 Top Class Call Girl Service BangaloreCall Girls Hebbal Just Call 👗 7737669865 👗 Top Class Call Girl Service Bangalore
Call Girls Hebbal Just Call 👗 7737669865 👗 Top Class Call Girl Service Bangaloreamitlee9823
 
Falcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to ProsperityFalcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to Prosperityhemanthkumar470700
 
👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...
👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...
👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...rajveerescorts2022
 
John Halpern sued for sexual assault.pdf
John Halpern sued for sexual assault.pdfJohn Halpern sued for sexual assault.pdf
John Halpern sued for sexual assault.pdfAmzadHosen3
 
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best ServicesMysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best ServicesDipal Arora
 
Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with CultureSeta Wicaksana
 
Monthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptxMonthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptxAndy Lambert
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1kcpayne
 
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Dave Litwiller
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityEric T. Tung
 
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...Sheetaleventcompany
 

Último (20)

MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLMONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
Call Girls Ludhiana Just Call 98765-12871 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 98765-12871 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 98765-12871 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 98765-12871 Top Class Call Girl Service Available
 
Call Girls Zirakpur👧 Book Now📱7837612180 📞👉Call Girl Service In Zirakpur No A...
Call Girls Zirakpur👧 Book Now📱7837612180 📞👉Call Girl Service In Zirakpur No A...Call Girls Zirakpur👧 Book Now📱7837612180 📞👉Call Girl Service In Zirakpur No A...
Call Girls Zirakpur👧 Book Now📱7837612180 📞👉Call Girl Service In Zirakpur No A...
 
Value Proposition canvas- Customer needs and pains
Value Proposition canvas- Customer needs and painsValue Proposition canvas- Customer needs and pains
Value Proposition canvas- Customer needs and pains
 
BAGALUR CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRL
BAGALUR CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRLBAGALUR CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRL
BAGALUR CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRL
 
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptxB.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
B.COM Unit – 4 ( CORPORATE SOCIAL RESPONSIBILITY ( CSR ).pptx
 
Call Girls Hebbal Just Call 👗 7737669865 👗 Top Class Call Girl Service Bangalore
Call Girls Hebbal Just Call 👗 7737669865 👗 Top Class Call Girl Service BangaloreCall Girls Hebbal Just Call 👗 7737669865 👗 Top Class Call Girl Service Bangalore
Call Girls Hebbal Just Call 👗 7737669865 👗 Top Class Call Girl Service Bangalore
 
Falcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to ProsperityFalcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to Prosperity
 
👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...
👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...
👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...
 
John Halpern sued for sexual assault.pdf
John Halpern sued for sexual assault.pdfJohn Halpern sued for sexual assault.pdf
John Halpern sued for sexual assault.pdf
 
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best ServicesMysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
 
Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with Culture
 
Monthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptxMonthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptx
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1
 
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League City
 
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
 

Dilmena Powerpoint

  • 1. Stephanie Nishi Spencer Lee Andrew Walnum Gurmeet Marwaha Period 5, Biotechnology
  • 2. The Scenario What can Biotex offer this scientist in order to avoid going out of business?
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.  
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.  
  • 18.